Data / Form D filings / DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc.: Form D filings
DiaMedica Therapeutics Inc., a biotechnology company in Minneapolis, MN, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on July 25, 2025, reports $30.1 million sold of a $30.1 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 301 CARLSON PARKWAY, SUITE 210, Minneapolis, MN, 55305
- Phone
- (763) 496-5454
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1401040
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | New notice | $30,100,000 | $30,100,000 | 14 | Jul 23, 2025 | sec.gov | |
| Jul 2, 2024 | New notice | $11,800,000 | $11,800,000 | 10 | Jun 28, 2024 | sec.gov | |
| Jun 27, 2023 | New notice | $37,536,853 | $37,536,853 | 34 | Jun 23, 2023 | sec.gov | |
| Apr 18, 2023 | New notice | $750,000 | $750,000 | 1 | Apr 10, 2023 | sec.gov | |
| Oct 6, 2021 | New notice | $29,999,995 | $29,999,995 | 10 | Sep 28, 2021 | sec.gov | |
| Apr 17, 2018 | New notice | $344,348 | $200,870 | $143,478 | 7 | Mar 29, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David J. Wambeke | Executive Officer | |
| Charles P. Semba | Director | |
| Lorianne Masuoka | Executive Officer | |
| Daniel T. O'Connor | Director | |
| Scott Kellen | Executive Officer | |
| Richard R. Kuntz | Director | |
| Michael R. Giuffre | Director | |
| Tanya N. Lewis | Director | |
| Rick Pauls | Executive Officer, Director | |
| James T. Parsons | Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Jul 21, 2025 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DiaMedica Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.